Adam Harrington

International Venture Investor I Executive & Entrepreneur Advisor I Corporate Builder I Multiple Exits I Multiple Failures

📍 United States🔄 Updated September 2026💼 16 investments📅 20 years investing🗓 Last invested Sep 2025
VC🌍 United StatesInvested this year
16
Total investments
8
Early stage
3
Mid stage
2
Late stage
20y
Years active

Portfolio

16 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Seed Investor
Sep 2025
New therapeutics company advancing a GLP1-RA for AUD and other addictive disorders.
Seed Investor
Sep 2025
Hologen builds multimodal foundation models, spanning real-world 3D imaging, clinical, genetic and omics data, for high-precision interventional inference in its growing portfolio of late-stage therapeutic programmes.
Senior Advisor and Investor
May 2025
MagiCup is the launch of a first-of-its-kind global youth sports brand — a purpose-driven international soccer tournament at Walt Disney World® debuting in 2026, uniting top 2013–2014 boys teams from around the world for a professionally produced, world-class competition and life-changing experience. What is MagiCup? One tournament. A world of opportunity. A generation of change. And a legacy just beginning. MagiCup is not just another youth soccer tournament — it is the pinnacle of what the global game can offer in youth sports and a bold new global brand and cultural force launching at a time when the world desperately needs something to believe in. MagiCup is positioned to be a high-impact global platform for youth empowerment and a dynamic media property with long-term commercial potential. Launched in partnership with Walt Disney World®, ESPN Wide World of Sports Complex, IdeaSport Foundation and PVBLIC Foundation — and aligned with the United Nations’ Football for the Goals program — MagiCup is where elite sport meets global storytelling and social transformation.
Angel Investor
Nov 2024
Paradigm Robotics builds next-generation robotic platform solutions for the most hazardous environments to serve those who serve.
Private Investor
Oct 2024
Welcome to Lyndra Therapeutics: Medicine, reinvented Imagine taking a week’s worth of medicine in a single dose, once a week. Four pills a month. Eventually, one pill a month. Lyndra Therapeutics’ LYNX™ drug delivery platform is making that possible. Lyndra Therapeutics is a clinical-stage biopharmaceutical company pioneering long-acting oral therapies. Lyndra is focused on commercializing therapies in central nervous system (CNS) disorders, with lead product candidate oral weekly risperidone (LYN-005) for the treatment of people living with schizophrenia and bipolar 1 disorder. The company is also committed to advancing its platform to tackle major public health and global health challenges, with therapies including oral weekly levomethadone and oral weekly buprenorphine for opioid use disorder, a monthly oral contraception pill and oral biweekly ivermectin for malaria eradication. Since its founding, partners have included the Bill & Melinda Gates Foundation, the NIH, AbbVie and Gilead Sciences, Inc. Lyndra is headquartered in Watertown, MA and has a state-of-the-art GMP manufacturing facility in Lexington, MA. Core purpose: reinvent medicine for a healthier world Core values: value every voice; resilient to the core; I contribute, we deliver Does Lyndra sound like a great fit for you? Join the Team: https://lyndra.com/about/join-the-team/
late stageBiotechnology
Seed Investor
Sep 2024
Enterprises rely on data to make brilliant decisions, identify opportunities and forecast the future. Yet, without the right data protection, visibility and control, your database becomes your biggest risk. At the same time, those who already have data security may be locked out of using their greatest asset. Velotix allows you to freely discover and use your data while remaining secure and compliant. Our automated data security platform, DSP, uses AI to enforce the right policies and grant access to the right people in a prompt and secure way.
Senior Advisor + Investor
Oct 2023
Cut your hiring time significantly—jobworX uses AI to quickly identify the best candidates, leveraging comprehensive personality assessments to ensure a perfect match to your job requirements and company culture.
Seed Investor
Nov 2021
Rhino Bitcoin is a simple, convenient and secure alternative banking solution that enables users to easily trade, save, spend, earn, borrow, pay and even mine bitcoin, directly from their smartphone.
Seed Investor
May 2020
At Nodis, we provide the world’s only color smart glass technology. Smart glass is glass with light transmission properties that can be changed when voltage is applied. With Nodis electronically controlled glass, the color and tint of any window, sunroof or skylight by electrically aligning nano-particles in a thin film within the glass or plastic. With the touch of a button, users can instantly change or tune the transparency of glass to help keep out harsh sunlight and 95% of harmful UV rays. Our technology effectively blocks UV and infrared rays regardless of whether the glass is in its clear or tinted state, helping keep cars, planes, yachts, homes, offices and artwork cooler and protected. Nodis smart glass is a critical enabler to smart building energy and comfort management. We license our color smart glass technology to glass manufacturers and provide nanoparticles to enable customer production of Nodis-based smart glass.
Seed Investor
Apr 2019
⚡️Effortlessly build Web3 apps. Hosting, ENS, Storage, Pinning & More! Built on IPFS, Ethereum, Filecoin, Arweave, Akash, etc. Supercharged by Fleek Network - (https://fleek.network)
Advisory Board Member + Investor
Mar 2019
Founded in 2016, Bloq builds the infrastructure, applications, and innovations that power Web3, as expressions of its Tokenization of Things™ methodology. Our projects include work in blockchain infrastructure, decentralized finance (DeFi), mining, metaverse, NFTs, staking, and more. Led by some of our industrys earliest figures, we are driven by our passion for building, our innate belief in the decentralized future, and our shared mission of advancing Web3’s promise.
Seed Investor
Dec 2018
Gen-zs largest social music streaming service - Stationhead allows music fans & artists around the world to connect, listen live, and stream together.
Strategic Advisor + Seed Investor
Oct 2018
Ubiety Technologies Inc. is a data and technology startup revolutionizing identity and presence monitoring in the residential sector with the first-of-its-kind digital home presence monitoring solution, HomeAware. Using proprietary sensor technology, cloud infrastructure, and cutting-edge AI capabilities, Ubiety’s data ecosystem enables the identification and better understanding of people and their presence in physical spaces, while being more privacy-sensitive than other technologies. To learn more, visit ubiety.io
Seed Investor
Oct 2018
Aclipse Therapeutics is focused on developing novel and highly differentiated drugs to address diseases with high unmet medical needs. Our strategy is reducing clinical development risk by combining a new and druggable understanding of disease pathways with a novel drug molecule that inhibits these pathways, allowing us to build upon existing nonclinical and clinical data while creating a significant patent barrier-to-entry.
Seed Investor
Sep 2018
Founded in 2016, GoodCell’s mission is to empower people to live longer, healthier lives by using their own blood for dynamic and comprehensive diagnostics, and ultimately life-saving cell therapies. We are comprised of a team cutting-edge scientists, experienced doctors and innovative entrepreneurs whose vision is to shape the future of personalized health as today’s science becomes tomorrow’s medicine. Find out more about the truth within you by visiting our website www.goodcell.com.
Show all 16 investments ↓
Experience · 24 entries
All (24)
Investments (16)
Founder (2)
Board (1)
2025
Seed Investor
Sep 2025
New therapeutics company advancing a GLP1-RA for AUD and other addictive disorders.
Seed Investor
Sep 2025
Hologen builds multimodal foundation models, spanning real-world 3D imaging, clinical, genetic and omics data, for high-precision interventional inference in its growing portfolio of late-stage therapeutic programmes.
Senior Advisor and Investor
May 2025
MagiCup is the launch of a first-of-its-kind global youth sports brand — a purpose-driven international soccer tournament at Walt Disney World® debuting in 2026, uniting top 2013–2014 boys teams from around the world for a professionally produced, world-class competition and life-changing experience. What is MagiCup? One tournament. A world of opportunity. A generation of change. And a legacy just beginning. MagiCup is not just another youth soccer tournament — it is the pinnacle of what the global game can offer in youth sports and a bold new global brand and cultural force launching at a time when the world desperately needs something to believe in. MagiCup is positioned to be a high-impact global platform for youth empowerment and a dynamic media property with long-term commercial potential. Launched in partnership with Walt Disney World®, ESPN Wide World of Sports Complex, IdeaSport Foundation and PVBLIC Foundation — and aligned with the United Nations’ Football for the Goals program — MagiCup is where elite sport meets global storytelling and social transformation.
2024
Angel Investor
Nov 2024
Paradigm Robotics builds next-generation robotic platform solutions for the most hazardous environments to serve those who serve.
Private Investor
Oct 2024
Welcome to Lyndra Therapeutics: Medicine, reinvented Imagine taking a week’s worth of medicine in a single dose, once a week. Four pills a month. Eventually, one pill a month. Lyndra Therapeutics’ LYNX™ drug delivery platform is making that possible. Lyndra Therapeutics is a clinical-stage biopharmaceutical company pioneering long-acting oral therapies. Lyndra is focused on commercializing therapies in central nervous system (CNS) disorders, with lead product candidate oral weekly risperidone (LYN-005) for the treatment of people living with schizophrenia and bipolar 1 disorder. The company is also committed to advancing its platform to tackle major public health and global health challenges, with therapies including oral weekly levomethadone and oral weekly buprenorphine for opioid use disorder, a monthly oral contraception pill and oral biweekly ivermectin for malaria eradication. Since its founding, partners have included the Bill & Melinda Gates Foundation, the NIH, AbbVie and Gilead Sciences, Inc. Lyndra is headquartered in Watertown, MA and has a state-of-the-art GMP manufacturing facility in Lexington, MA. Core purpose: reinvent medicine for a healthier world Core values: value every voice; resilient to the core; I contribute, we deliver Does Lyndra sound like a great fit for you? Join the Team: https://lyndra.com/about/join-the-team/
late stageBiotechnology
Show all 24 entries ↓
Investment activity
2006–2025 · 16 investments
2006120184201922020120211202312024320253
Recent (last 2 years)Earlier